Skip to content

WallFlex™ M00547520Recalls & reported problems

Boston Scientific Corporation · Stent System · Class 2 · Implant

All models of WallFlex (4)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00191506044510), received between Aug 19, 2026 and Aug 19, 2026 — classified as 1 injury.

The most frequently reported specific device problem is “Migration” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Migration1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 19, 2026Migration

    It was reported to Boston Scientific Corporation that a Wall flex Biliary Plus RX Fully Covered Stent was implanted in the stomach to treat a malignancy during an EUS-guided Hepatic gastrostomy (EUS-HGS) procedure performed on (b)(6) 2026. The patient's anatomy was not dilated prior to stent placement. During the procedure, the stent was successfully implanted. However, during a follow-up evaluation on (b)(6) 2026, a computed tomography (CT) scan revealed that the Wall Flex biliary stent had migrated into the stomach. A laparoscopic procedure was subsequently performed, and the stent was successfully explanted.There were no patient complications reported as a result of this event and the patient condition after the procedure was reported to be stable.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50334646 ↗

Other Stents, drains and dilators for the biliary ducts devices

All Stents, drains and dilators for the biliary ducts devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page